Female sex and the use of anti-allergic agents increase the risk of developing cutaneous rash associated with nevirapine therapy.
Antinori A, Baldini F, Girardi E, Cingolani A, Zaccarelli M, Di Giambenedetto S, Barracchini A, De Longis P, Murri R, Tozzi V, Ammassari A, Rizzo MG, Ippolito G, De Luca A.
Antinori A, et al. Among authors: cingolani a.
AIDS. 2001 Aug 17;15(12):1579-81. doi: 10.1097/00002030-200108170-00018.
AIDS. 2001.
PMID: 11504993